Source comparison
Best CJC-1295 no DAC & Ipamorelin Dosage Body Recomposition 2026: Protocol Comparison
Before selecting a dosing protocol, researchers should understand how frequency, timing, and adjunct compounds affect outcomes. The table below compares the three most common approaches. Conservative Single Dose 100mcg Once daily 30–60 min before sleep 150–180
This comparison does not assign a generated winner or score.
- Before selecting a dosing protocol, researchers should understand how frequency, timing, and adjunct compounds affect outcomes. The table below compares the three most common approaches.
- Conservative Single Dose
- 100mcg
- Once daily
- 30–60 min before sleep
- 150–180% over baseline
- First-time peptide users, older populations (50+), or those prioritizing recovery over fat loss
- Lowest risk of side effects, still produces measurable recomposition over 12–16 weeks
- Standard Dual Dose
- 100–150mcg
- Twice daily
- Morning fasted + pre-sleep
- 200–250% over baseline
- Most researchers seeking balanced fat loss and lean mass preservation
- Optimal risk-reward ratio. Dual dosing amplifies results without receptor saturation
- Aggressive Dual Dose
- 200mcg
- 250–300% over baseline
- Experienced peptide users with established baseline response, aggressive recomposition timelines
- Marginal gains over standard dual dose, higher incidence of transient water retention and joint stiffness
- Single Dose with Adjunct
- 150mcg
- Pre-sleep
- 180–220% over baseline (peptides alone)
- Researchers combining peptides with other growth-factor modulators like MK 677
- MK 677 adds continuous ghrelin receptor stimulation. Synergistic but requires careful IGF-1 monitoring